10 things you need to know today: December 23, 2021

The FDA authorizes Pfizer's pill to treat COVID-19, South Africa says Omicron cases are dropping as fast as they rose, and more

Pfizer world headquarters
Pfizer world headquarters
(Image credit: KENA BETANCUR/AFP via Getty Images)

1. FDA authorizes Pfizer's pill to treat COVID-19

The Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill Paxlovid to treat early COVID-19 cases, making it the first drug approved for people to take at home to prevent severe symptoms. The milestone came as infections and hospitalizations rise and authorities warn of a potential flood of new cases from the fast-spreading Omicron variant. Another antiviral pill, developed by Merck, is expected to receive authorization soon. Health experts have high expectations for Pfizer's drug due to its mild side effects and tests showing it reduces hospitalizations and deaths by nearly 90 percent among patients at risk for severe disease. "The efficacy is high, the side effects are low, and it's oral. It checks all the boxes," said Dr. Gregory Poland of the Mayo Clinic.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.